• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Progressive microvascular failure in acute ischemic stroke: A systematic review, meta-analysis, and time-course analysis.急性缺血性脑卒中中渐进性微血管衰竭:系统评价、荟萃分析及时间进程分析。
J Cereb Blood Flow Metab. 2024 Feb;44(2):192-208. doi: 10.1177/0271678X231216766. Epub 2023 Nov 28.
2
Outcomes of Bridging Intravenous Thrombolysis Versus Endovascular Therapy Alone in Late-Window Acute Ischemic Stroke.静脉溶栓桥接治疗与单纯血管内治疗对急性缺血性脑卒中晚期患者的疗效比较。
Stroke. 2024 Jul;55(7):1767-1775. doi: 10.1161/STROKEAHA.124.046495. Epub 2024 May 15.
3
Impact of Collateral Status on Successful Revascularization in Endovascular Treatment: A Systematic Review and Meta-Analysis.侧支循环状态对血管内治疗成功再血管化的影响:一项系统评价和荟萃分析
Cerebrovasc Dis. 2016;41(1-2):27-34. doi: 10.1159/000441803. Epub 2015 Nov 19.
4
Endovascular treatment or general treatment: how should acute ischemic stroke patients choose to benefit from them the most?: A systematic review and meta-analysis.血管内治疗还是一般治疗:急性缺血性中风患者应如何选择以最大程度地从中获益?一项系统评价与荟萃分析。
Medicine (Baltimore). 2020 May;99(20):e20187. doi: 10.1097/MD.0000000000020187.
5
Endovascular thrombectomy for DAWN- and DEFUSE-3 ineligible acute ischemic stroke patients: a systematic review and meta-analysis.血管内血栓切除术治疗不适合 DAWN 和 DEFUSE-3 的急性缺血性脑卒中患者:系统评价和荟萃分析。
J Neurol. 2024 May;271(5):2230-2237. doi: 10.1007/s00415-024-12198-3. Epub 2024 Feb 3.
6
Adjunctive intra-arterial thrombolysis following successful endovascular reperfusion in acute ischemic stroke: a systematic review and meta-analysis of seven randomized controlled trials.急性缺血性卒中血管内再灌注成功后辅助动脉内溶栓治疗:七项随机对照试验的系统评价和荟萃分析
J Neurol. 2025 Apr 17;272(5):345. doi: 10.1007/s00415-025-13092-2.
7
Safety and Effectiveness Analysis of Endovascular Treatment versus Standard Medication Treatment in Patients with Progressive Acute Ischemic Stroke with Large Vessel Occlusion Stroke in the Ultra-Late Time Window: A Propensity Score Matched Cohort Study.超晚期时间窗内进展性急性缺血性卒中伴大血管闭塞患者血管内治疗与标准药物治疗的安全性和有效性分析:一项倾向评分匹配队列研究
World Neurosurg. 2025 Jan;193:619-627. doi: 10.1016/j.wneu.2024.09.126. Epub 2024 Oct 22.
8
Late Lesion Growth following Endovascular Therapy: Is 24 h Too Early to Assess Acute Infarct Size Including the Effects of Secondary Injury?血管内治疗后晚期病变生长:评估急性梗死面积(包括继发性损伤的影响),24小时是否太早?
Cerebrovasc Dis. 2025;54(1):129-137. doi: 10.1159/000536470. Epub 2024 Feb 27.
9
Impact of stroke imaging selection modality on endovascular thrombectomy outcomes in the early and extended time windows: A meta-analysis.卒中成像选择方式对早期和延长时间窗内血管内血栓切除术结局的影响:一项荟萃分析。
Brain Behav. 2024 Aug;14(8):e3530. doi: 10.1002/brb3.3530.
10
Endovascular Thrombectomy for Carotid Pseudo-Occlusion in the Setting of Acute Ischemic Stroke: A Comparative Systematic Review and Meta-analysis.血管内血栓切除术治疗急性缺血性脑卒中时的颈动脉假性闭塞:一项比较系统评价和荟萃分析。
AJNR Am J Neuroradiol. 2024 Sep 9;45(9):1241-1245. doi: 10.3174/ajnr.A8268.

引用本文的文献

1
Reperfusion failure after successful thrombectomy of large vessel occlusion stroke: clinical and imaging evidence.大血管闭塞性卒中成功取栓术后的再灌注失败:临床及影像学证据
Front Neurol. 2025 Aug 22;16:1639880. doi: 10.3389/fneur.2025.1639880. eCollection 2025.
2
Therapeutic potential of natural products in ischemic stroke: targeting angiogenesis.天然产物在缺血性脑卒中治疗中的潜力:靶向血管生成
Front Pharmacol. 2025 Jun 18;16:1579172. doi: 10.3389/fphar.2025.1579172. eCollection 2025.
3
Inhibition of Cathepsin B Ameliorates Murine Cognitive Dysfunction and Neuronal Damage in Ischemic Stroke by Inhibiting Mitochondrial Apoptosis and Drp1-Mediated Mitochondrial Fission.抑制组织蛋白酶B通过抑制线粒体凋亡和动力相关蛋白1(Drp1)介导的线粒体分裂改善缺血性脑卒中小鼠的认知功能障碍和神经元损伤。
Mol Neurobiol. 2025 May 30. doi: 10.1007/s12035-025-05094-y.
4
Melatonin Promotes Cerebral Angiogenesis in Ischemic Mice via BMP6/Smad1/5/9 Pathway.褪黑素通过BMP6/Smad1/5/9信号通路促进缺血小鼠的脑内血管生成。
Mol Neurobiol. 2025 Apr 25. doi: 10.1007/s12035-025-04969-4.
5
Development of a multi-scale nanofiber scaffold platform for structurally and functionally replicated artificial perforating arteries.用于结构和功能复制的人工穿支动脉的多尺度纳米纤维支架平台的开发。
Bioprocess Biosyst Eng. 2025 Mar;48(3):483-492. doi: 10.1007/s00449-024-03122-0. Epub 2024 Dec 26.
6
Intra-arterial tenecteplase after successful endovascular therapy (ANGEL-TNK): protocol of a multicentre, open-label, blinded end-point, prospective, randomised trial.血管内治疗成功后动脉内注射替奈普酶(ANGEL-TNK):一项多中心、开放标签、终点设盲、前瞻性随机试验方案
Stroke Vasc Neurol. 2024 Nov 21. doi: 10.1136/svn-2024-003318.
7
Perfusion Abnormalities on 24-Hour Perfusion Imaging in Patients With Complete Endovascular Reperfusion.24 小时灌注成像中完全血管内再灌注患者的灌注异常。
Stroke. 2024 Sep;55(9):2315-2324. doi: 10.1161/STROKEAHA.124.047441. Epub 2024 Aug 15.

本文引用的文献

1
No-Reflow Post-Recanalization in Acute Ischemic Stroke: Mechanisms, Measurements, and Molecular Markers.急性缺血性脑卒中再通后无复流:机制、测量及分子标志物。
Stroke. 2023 Sep;54(9):2472-2480. doi: 10.1161/STROKEAHA.123.044240. Epub 2023 Aug 3.
2
No-reflow phenomenon in stroke patients: A systematic literature review and meta-analysis of clinical data.脑卒中患者无再流现象:临床数据的系统文献复习和荟萃分析。
Int J Stroke. 2024 Jan;19(1):58-67. doi: 10.1177/17474930231180434. Epub 2023 Jun 8.
3
Elevated pulsatility index is associated with poor functional outcome in stroke patients treated with thrombectomy: A retrospective cohort study.经皮血管内介入治疗的脑卒中患者搏动指数升高与预后不良相关:一项回顾性队列研究。
CNS Neurosci Ther. 2022 Oct;28(10):1568-1575. doi: 10.1111/cns.13888. Epub 2022 Jun 16.
4
Full Reperfusion Without Functional Independence After Mechanical Thrombectomy in the Anterior Circulation : Performance of Prediction Models Before Versus After Treatment Initiation.机械取栓后无功能独立的完全再灌注在前循环中的表现:治疗开始前后预测模型的性能。
Clin Neuroradiol. 2022 Dec;32(4):987-995. doi: 10.1007/s00062-022-01166-x. Epub 2022 May 9.
5
Prevalence and Significance of Impaired Microvascular Tissue Reperfusion Despite Macrovascular Angiographic Reperfusion (No-Reflow).尽管大血管血管造影再通(无再流),但存在微血管组织再灌注受损的患病率和意义(No-Reflow)。
Neurology. 2022 Feb 22;98(8):e790-e801. doi: 10.1212/WNL.0000000000013210. Epub 2021 Dec 14.
6
Early Neurological Deterioration and Hypoperfusion Volume Ratio on Arterial Spin Labeling in Patients with Acute Ischemic Stroke.急性缺血性脑卒中患者动脉自旋标记的早期神经恶化与低灌注容积比。
J Stroke Cerebrovasc Dis. 2021 Aug;30(8):105885. doi: 10.1016/j.jstrokecerebrovasdis.2021.105885. Epub 2021 Jun 6.
7
Infarct Growth despite Successful Endovascular Reperfusion in Acute Ischemic Stroke: A Meta-analysis.急性缺血性脑卒中血管内再通成功后仍出现梗死进展:一项荟萃分析。
AJNR Am J Neuroradiol. 2021 Aug;42(8):1472-1478. doi: 10.3174/ajnr.A7177. Epub 2021 Jun 3.
8
Does Src Kinase Mediated Vasoconstriction Impair Penumbral Reperfusion?Src激酶介导的血管收缩是否会损害半暗带再灌注?
Stroke. 2021 Jun;52(6):e250-e258. doi: 10.1161/STROKEAHA.120.032737. Epub 2021 May 5.
9
A lower admission level of interleukin-6 is associated with first-pass effect in ischemic stroke patients.白细胞介素-6 较低的入院水平与缺血性脑卒中患者的首次通过效应相关。
J Neurointerv Surg. 2022 Mar;14(3):248-251. doi: 10.1136/neurintsurg-2021-017334. Epub 2021 Apr 21.
10
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.

急性缺血性脑卒中中渐进性微血管衰竭:系统评价、荟萃分析及时间进程分析。

Progressive microvascular failure in acute ischemic stroke: A systematic review, meta-analysis, and time-course analysis.

机构信息

Department of Neurological Surgery, Columbia University Irving Medical Center, New York, NY, USA.

Departments of Psychiatry and Radiology, Columbia University Irving Medical Center, New York, NY, USA.

出版信息

J Cereb Blood Flow Metab. 2024 Feb;44(2):192-208. doi: 10.1177/0271678X231216766. Epub 2023 Nov 28.

DOI:10.1177/0271678X231216766
PMID:38016953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10993872/
Abstract

This systematic review, meta-analysis, and novel time course analysis examines microvascular failure in the treatment of acute ischemic stroke (AIS) patients undergoing endovascular therapy (EVT) and/or thrombolytic administration for stroke management. A systematic review and meta-analysis following PRIMSA-2020 guidelines was conducted along with a novel curve-of-best fit analysis to elucidate the time-course of microvascular failure. Scopus and PubMed were searched using relevant keywords to identify studies that examine recanalization and reperfusion assessment of AIS patients following large vessel occlusion. Meta-analysis was conducted using a random-effects model. Curve-of-best-fit analysis of microvascular failure rate was performed with a negative exponential model. Twenty-seven studies with 1151 patients were included. Fourteen studies evaluated patients within a standard stroke onset-to-treatment time window (≤6 hours after last known normal) and thirteen studies had an extended time window (>6 hours). Our analysis yields a 22% event rate of microvascular failure following successful recanalization (95% CI: 16-30%). A negative exponential curve modeled a microvascular failure rate asymptote of 28.5% for standard time window studies, with no convergence of the model for extended time window studies. Progressive microvascular failure is a phenomenon that is increasingly identified in clinical studies of AIS patients undergoing revascularization treatment.

摘要

本系统评价、荟萃分析和新的时间进程分析检查了接受血管内治疗 (EVT) 和/或溶栓治疗的急性缺血性卒中 (AIS) 患者的微血管衰竭。按照 PRIMSA-2020 指南进行了系统评价和荟萃分析,并进行了新的最佳拟合曲线分析,以阐明微血管衰竭的时间进程。使用相关关键字在 Scopus 和 PubMed 上搜索了研究,以确定检查大血管闭塞后 AIS 患者再通和再灌注评估的研究。使用随机效应模型进行荟萃分析。使用负指数模型对微血管衰竭率进行最佳拟合曲线分析。纳入了 27 项研究,共 1151 例患者。14 项研究评估了在标准卒中发病至治疗时间窗(最后一次正常后≤6 小时)内的患者,13 项研究的时间窗延长(>6 小时)。我们的分析显示,成功再通后微血管衰竭的发生率为 22%(95%CI:16-30%)。标准时间窗研究中,负指数曲线模拟微血管衰竭率的渐近值为 28.5%,而延长时间窗研究中,该模型没有收敛。渐进性微血管衰竭是在接受血管再通治疗的 AIS 患者的临床研究中越来越多地发现的一种现象。